Home » Industry At-A-Glance » CHI Industry Details
 |
deCODE genetics |
|
|
584 Broadway, Suite 608
New York, NY 10012
Phone: (212) 343-2819
|
|
|
|
|
|
Year Founded: |
1996 |
|
|
Organization Type:
|
Diagnostics, Drug Discovery
|
|
|
|
Disease Focus: |
Atrial Fibrillation
,
Cancer (misc)
,
Cardiovascular Disorder (misc)
,
Diabetes -- Type 2 (non-insulin dependent)
,
Inflammation (general)
,
Metabolic disorders (misc)
,
Myocardial infarction (heart attack)
,
Obesity
,
Pain control
,
Peripheral vascular disease
,
Stroke
|
|
|
|
Region: |
Other
|
|
|
Ownership: |
Private |
|
|
Stock Symbol: |
DCGN |
|
|
|
|
|
Key Personnel
-
Jeffrey Gulcher, M.D., Ph.D., Chief Scientific Officer
-
Kari Stefansson, M.D., President, CEO and Chairman
-
Lance Thibault, CFO and Treasurer
|
|